NextCure, Inc.NXTCNASDAQ
Loading
Year-over-year operating cash flow growth rate
| Period | Value |
|---|---|
| Q4 2025 | -21.86% |
| Q3 2025 | 72.40% |
| Q2 2025 | -74.80% |
| Q1 2025 | -86.45% |
| Q4 2024 | 39.16% |
| Q3 2024 | -17.16% |
| Q2 2024 | 22.45% |
| Q1 2024 | -18.14% |
| Q4 2023 | 16.50% |
| Q3 2023 | 13.35% |
| Q2 2023 | 0.22% |
| Q1 2023 | -65.15% |
| Q4 2022 | 40.34% |
| Q3 2022 | -3.53% |
| Q2 2022 | 6.20% |
| Q1 2022 | -14.86% |
| Q4 2021 | -6.22% |
| Q3 2021 | 26.48% |
| Q2 2021 | -23.80% |
| Q1 2021 | -121.58% |
| Q4 2020 | 59.94% |
| Q3 2020 | -26.30% |
| Q2 2020 | -17.13% |
| Q1 2020 | -6.04% |
| Q4 2019 | -25.72% |
| Q3 2019 | 25.06% |
| Q2 2019 | -49.79% |
| Q1 2019 | -131.51% |
| Q4 2018 | 576.18% |
| Q3 2018 | 4.80% |
| Q2 2018 | -3.21% |
| Q1 2018 | 0.00% |